NCT06622226 - A Study of ONO-7018 in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 27, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

December 31, 2029

Conditions

Non Hodgkin Lymphoma

Interventions

DRUG

ONO-7018

ONO-7018 tablet(s) are administered orally.

Trial Locations (6)

Nagoya City University Hospital, Nagoya

National Hospital Organization Shibukawa Medical Center, Shibukawa-shi

Hiroshima Red Cross Hospital Atomic-bomb Survivors Hospital, Hiroshima

National Hospital Organization Sendai Medical Center, Sendai

The Cancer Institute Hospital of JFCR, Koto-ku

National Hospital Organization Osaka National Hospital, Osaka